http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484469-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111484469-B
titleOfInvention Synthesis method and application of lead compound of pyranidene malononitrile photosensitizer
abstract Synthesis method of lead compound of pyrylanidene malononitrile type photosensitizer and application thereof Small molecule photosensitizer (PS1-3), the structure is shown in formula (I), and its photodynamic properties and fluorescence properties are different. The invention also discloses the application of tumor imaging and treatment at the cell level. The lead compound in the present invention has the characteristics of simple structure, small molecular weight, definite chemical structure, easy preparation, purification and further modification, and low cytotoxicity. Cell experiments have shown that near-infrared imaging and photodynamic therapy of cells can be achieved with the help of an external visible light source, which significantly inhibits tumor growth. Therefore, the single-molecule photosensitizer lead compound involved in the present invention has a good application prospect in breast cancer treatment.
priorityDate 2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-9823708-D0
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415709274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424499418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150009356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154438332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433567920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID186148

Total number of triples: 32.